PDS Biotechnology Reports Second Quarter 2019 Financial Results And Provides Business Update

NEXT STORY
Teleflex Announces Publication of “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device”
PREV STORY
Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease

author_avatar
NASDAQ Market News

Jounce Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

author_avatar
NASDAQ Market News

OSE Immunotherapeutics and Nantes University Hospital Announce Initiation of a Phase 1/2 Clinical Trial to Evaluate CD28 Antagonist FR104 in Patients Undergoing Renal Transplantation

author_avatar
NASDAQ Market News